Rapid, Efficient Imaging
Yang Chen
Research Assistant
University of Southern California, United States
Zhehao Hu, PhD
Research Assistant
University of Southern California
Los Angeles, California, United States
Debiao Li, PhD
Professor
Cedars-Sinai Medical Center
Los Angeles, California, United States
Anthony G. Christodoulou, PhD
Assistant Professor
Cedars-Sinai Medical Center
Los Angeles, California, United States
Qi Yang, MD
Chairman
Chaoyang Hospital
Beijing, Beijing, China (People's Republic)
Zhaoyang Fan, PhD
Associate Professor
University of Southern California, California, United States
Zhaoyang Fan, PhD
Associate Professor
University of Southern California, California, United States
Xin Liu, MD
Residence
Chaoyang Hospital, Guangdong, China (People's Republic)
Six consecutive patients suspected of cardiomyopathies were enrolled into an IRB-approved MR study. MT-MACS (Figure 1) was acquired after initial three-plane localizer. Major imaging parameters included: coronal orientation, FOV=224×224×162.4 mm3, spatial resolution=1.4×1.4×2.8 mm3 (interpolated to 1.4 mm3 isotropic), T2-prep duration=60 ms, TR/TE1/TE2=3.94/1.23/2.46 ms, 500 readouts after each T2IR, total scan time=10 min. Image reconstruction was performed offline to generate water-only images with multiple contrast weightings (i.e. bright-blood [BB], dark-blood [DB], gray-blood [GB]) and corresponding cine series as well as fat-only images. Qualitative (image quality score 1: poor, 4: excellent) and quantitative (left ventricular ejection fraction, wall thickness, and vessel diameter) were performed.
Results:
All cases received quality score of 3 to 4 (mean = 3.3). MT-MACS was able to provide multi-contrast water-only and fat images with flexibility of reformation for best visualization (Figure 2). Right ventricle/atrial enlargement was detected in 2 cases, ventricular hypertrophy was detected in 4 cases, aortic enlargement was detected in 1 case, and thrombus in atrial appendage was detected in 1 case. These findings and quantitative measurements consistent with transthoracic or transesophagus echoes.
Conclusion:
We demonstrated the clinical feasibility of using MT-MACS for cardiomyopathies assessment. Evaluation of its performance in more diverse cardiovascular diseases is underway.